Cronos has announced plans to acquire CanAdelaar B V in the Netherlands, giving the company a strategic foothold in the European cannabis market. The move reflects a growing trend of North American operators pursuing global expansion as international programs evolve.

Wisconsin hemp growers and processors are scrambling after federal legislation quietly banned many hemp-derived THC products. The move threatens major revenue streams and pushes the state’s hemp industry into emergency adaptation mode.

A new multi-state study found rising cases of occupational asthma — and some fatalities — among cannabis cultivation, trimming, and packaging workers. The research highlights urgent gaps in workplace safety as the cannabis industry scales and underscores the need for stronger compliance and protection.

A woman-led biotech company is developing prescription-grade cannabinoid treatments for women’s health conditions like endometriosis. Their work aims to bring cannabis into mainstream medical and pharmaceutical channels — marking a breakthrough moment for both science and the cannabis industry.

Curaleaf reported Q3 revenue of $320 million and a net loss of $54.5 million, reflecting both strength and ongoing financial strain across large multi-state cannabis operators. The results highlight the industry’s shift toward sustainable growth and disciplined risk management.

Colombian President Gustavo Petro publicly urged Donald Trump to legalize U.S. cannabis exports, signaling how international diplomacy and cannabis reform are becoming intertwined. The move underscores Colombia’s ambitions to lead global cannabis trade as the U.S. faces pressure to modernize its federal policies.

A new national study by MRI-Simmons reveals that 31% of U.S. adults have used cannabis in the past six months, confirming its place in mainstream wellness culture. As acceptance grows, cannabis is being redefined from a taboo topic to a trusted part of health and lifestyle — bringing new opportunities and challenges for businesses.